Marcus Schmidt

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Venues

Cancers

Biomedicines

NPJ breast cancer

International journal of molecular sciences

University Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Medical Center

Germany

Professor and Head of Molecular Oncology :: Obstetrics and Gynecology

University Medical Center

Germany

Attending Physician :: Obstetrics and Gynecology

University Medical Center

Germany

Resident :: Department of Obstetrics and Gynecology

Mayo Clinic

United States

Visitin Resident

University Hospital

Germany

Resident :: Department of Pathology

Royal London Hospital

United Kingdom

Visiting Resident :: Department of Morbid Anatomy

Publications

Ina Shehaj, Slavomir Krajnak, Katrin Almstedt, Yaman Degirmenci, Sophia Herzog, Antje Lebrecht, Valerie Catherine Linz, Roxana Schwab, Kathrin Stewen, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heimes
BRCA1 , BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines 12 (6) (2024)
Ina Shehaj, Maria Schröder, Valerie Catherine Linz, Slavomir Krajnak, Katrin Almstedt, Kathrin Stewen, Roxana Schwab, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heimes
Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers. Cancers 16 (7) (2024)
Ina Shehaj, Maria Schröder, Valerie Catherine Linz, Slavomir Krajnak, Katrin Almstedt, Kathrin Stewen, Roxana Schwab, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heimes
Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers. Cancers 16 (7) (2024)
Rudolf Weide, Stefan Feiten, Christina Waßmann, Bernhard Rendenbach, Ute Braun, Oswald Burkhard, Peter Ehscheidt, Marcus Schmidt
Metastatic Breast Cancer: Prolonging Life in Routine Oncology Care. Cancers 16 (7) (2024)
Rudolf Weide, Stefan Feiten, Christina Waßmann, Bernhard Rendenbach, Ute Braun, Oswald Burkhard, Peter Ehscheidt, Marcus Schmidt
Metastatic Breast Cancer: Prolonging Life in Routine Oncology Care. Cancers 16 (7) (2024)
Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, Andreas Schneeweiss, Eva-Maria Grischke, Grischa Wachsmann, Helmut Forstbauer, Michael Untch, Frederik Marmé, Jens-Uwe Blohmer, Christian Jackisch, Jens Huober, Elmar Stickeler, Mattea Reinisch, Theresa Link, Bruno Valentin Sinn, Wolfgang Janni, Carsten Denkert, Sabine Seiler, Christine Solbach, Sabine Schmatloch, Julia Rey, Sibylle Loibl
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer. NPJ breast cancer 10 (1) (2024)
Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, Andreas Schneeweiss, Eva-Maria Grischke, Grischa Wachsmann, Helmut Forstbauer, Michael Untch, Frederik Marmé, Jens-Uwe Blohmer, Christian Jackisch, Jens Huober, Elmar Stickeler, Mattea Reinisch, Theresa Link, Bruno Valentin Sinn, Wolfgang Janni, Carsten Denkert, Sabine Seiler, Christine Solbach, Sabine Schmatloch, Julia Rey, Sibylle Loibl
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer. NPJ breast cancer 10 (1) (2024)
Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, Andreas Schneeweiss, Eva-Maria Grischke, Grischa Wachsmann, Helmut Forstbauer, Michael Untch, Frederik Marmé, Jens-Uwe Blohmer, Christian Jackisch, Jens Huober, Elmar Stickeler, Mattea Reinisch, Theresa Link, Bruno Valentin Sinn, Wolfgang Janni, Carsten Denkert, Sabine Seiler, Christine Solbach, Sabine Schmatloch, Julia Rey, Sibylle Loibl
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer. NPJ breast cancer 10 (1) (2024)
Rudolf Weide, Stefan Feiten, Christina Waßmann, Bernhard Rendenbach, Ute Braun, Oswald Burkhard, Peter Ehscheidt, Marcus Schmidt
Metastatic Breast Cancer: Prolonging Life in Routine Oncology Care. Cancers 16 (7) (2024)
Ina Shehaj, Slavomir Krajnak, Katrin Almstedt, Yaman Degirmenci, Sophia Herzog, Antje Lebrecht, Valerie Catherine Linz, Roxana Schwab, Kathrin Stewen, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heimes
BRCA1 , BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines 12 (6) (2024)
Christoph Thomssen, Martina Vetter, Eva Johanna Kantelhardt, Christoph Meisner, Marcus Schmidt, Pierre M Martin, Florian Clatot, Doris Augustin, Volker Hanf, Daniela Paepke, Wolfgang Meinerz, Gerald Hoffmann, Wolfgang Wiest, Fred C G J Sweep, Manfred Schmitt, Fritz Jänicke, Sibylle Loibl, Gunter von Minckwitz, Nadia Harbeck, null null
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers 15 (5) (2023)
Katrin Almstedt, Lisa Krauthauser, Franziska Kappenberg, Daniel-Christoph Wagner, Anne-Sophie Heimes, Marco J Battista, Katharina Anic, Slavomir Krajnak, Antje Lebrecht, Roxana Schwab, Walburgis Brenner, Wolfgang Weikel, Jörg Rahnenführer, Jan G Hengstler, Wilfried Roth, Annette Hasenburg, Kathrin Stewen, Marcus Schmidt
Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer. Cancers 15 (5) (2023)
Katrin Almstedt, Lisa Krauthauser, Franziska Kappenberg, Daniel-Christoph Wagner, Anne-Sophie Heimes, Marco J Battista, Katharina Anic, Slavomir Krajnak, Antje Lebrecht, Roxana Schwab, Walburgis Brenner, Wolfgang Weikel, Jörg Rahnenführer, Jan G Hengstler, Wilfried Roth, Annette Hasenburg, Kathrin Stewen, Marcus Schmidt
Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer. Cancers 15 (5) (2023)
Cristina L Cotarelo, Arno Schad, Marcus Schmidt, Arnd Hönig, Jonathan Paul Sleeman, Sonja Thaler
Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases. Cancers 15 (6) (2023)
Anne-Sophie Heimes, Natali Riedel, Katrin Almstedt, Slavomir Krajnak, Roxana Schwab, Kathrin Stewen, Antje Lebrecht, Marco Johannes Battista, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt
Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer. International journal of molecular sciences 24 (20) (2023)
Cristina L Cotarelo, Arno Schad, Marcus Schmidt, Arnd Hönig, Jonathan Paul Sleeman, Sonja Thaler
Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases. Cancers 15 (6) (2023)
Christoph Thomssen, Martina Vetter, Eva Johanna Kantelhardt, Christoph Meisner, Marcus Schmidt, Pierre M Martin, Florian Clatot, Doris Augustin, Volker Hanf, Daniela Paepke, Wolfgang Meinerz, Gerald Hoffmann, Wolfgang Wiest, Fred C G J Sweep, Manfred Schmitt, Fritz Jänicke, Sibylle Loibl, Gunter von Minckwitz, Nadia Harbeck, null null
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers 15 (5) (2023)
Roxana Schwab, Annika Droste, Kathrin Stewen, Tania Elger, Susanne Theis, Anne-Sophie Heimes, Katharina Peters, Marcus Schmidt, Walburgis Brenner, Annette Hasenburg
Resilience as a Source of Easement to Health-Related Worries in Women at Increased Risk for Breast or Ovarian Cancer During the COVID-19 Pandemic. International journal of general medicine 15 (2022)
Mona W Schmidt, Marco J Battista, Marcus Schmidt, Monique Garcia, Timo Siepmann, Annette Hasenburg, Katharina Anić
Efficacy and Safety of Immunotherapy for Cervical Cancer-A Systematic Review of Clinical Trials. Cancers 14 (2) (2022)
Anne-Sophie Heimes, Katrin Almstedt, Slavomir Krajnak, Anne Runkel, Annika Droste, Roxana Schwab, Kathrin Stewen, Antje Lebrecht, Marco J Battista, Walburgis Brenner, Annette Hasenburg, Mathias Gehrmann, Jan G Hengstler, Marcus Schmidt
Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer. Biomedicines 10 (10) (2022)
Katharina Anic, Mona W Schmidt, Larissa Furtado, Lina Weidenbach, Marco J Battista, Marcus Schmidt, Roxana Schwab, Walburgis Brenner, Christian Ruckes, Johannes Lotz, Karl J Lackner, Annbalou Hasenburg, Annette Hasenburg
Intermittent Fasting-Short- and Long-Term Quality of Life, Fatigue, and Safety in Healthy Volunteers: A Prospective, Clinical Trial. Nutrients 14 (19) (2022)
Karolina Edlund, Katrin Madjar, Antje Lebrecht, Bahriye Aktaş, Henryk Pilch, Gerald Hoffmann, Manfred Hofmann, Hans-Christian Kolberg, Daniel Boehm, Marco Battista, Martina Seehase, Kathrin Stewen, Susanne Gebhard, Cristina Cadenas, Rosemarie Marchan, Walburgis Brenner, Annette Hasenburg, Heinz Koelbl, Christine Solbach, Mathias Gehrmann, Berno Tanner, Karsten E Weber, Sibylle Loibl, Agapios Sachinidis, Jörg Rahnenführer, Marcus Schmidt, Jan G Hengstler
Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (8) (2021)
Sven Roßwag, Cristina L Cotarelo, Klaus Pantel, Sabine Riethdorf, Jonathan P Sleeman, Marcus Schmidt, Sonja Thaler
Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2- Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2- Breast Cancer. Cancers 13 (8) (2021)
Slavomir Krajnak, Thomas Decker, Lukas Schollenberger, Christian Rosé, Christian Ruckes, Tanja Fehm, Christoph Thomssen, Nadia Harbeck, Marcus Schmidt
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2- breast cancer resistant to endocrine therapy: VinoMetro-AGO-B-046. Journal of cancer research and clinical oncology 147 (11) (2021)
Marcus Schmidt, Anne-Sophie Heimes
Immunomodulating Therapies in Breast Cancer-From Prognosis to Clinical Practice. Cancers 13 (19) (2021)
Kerstin Riecke, Volkmar Mueller, Rudolf Weide, Marcus Schmidt, Tjoung-Won Park-Simon, Volker Möbus, Christoph Mundhenke, Arkadius Polasik, Kristina Lübbe, Tobias Hesse, Elena Laakmann, Marc Thill, Peter Andreas Fasching, Carsten Denkert, Tanja Fehm, Valentina Nekljudova, Julia Rey, Sibylle Loibl, Isabell Witzel
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic Scores. Cancers 13 (4) (2021)
Marcus Schmidt, Karolina Edlund, Jan G Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Antje Lebrecht, Slavomir Krajnak, Marco J Battista, Walburgis Brenner, Annette Hasenburg, Jörg Rahnenführer, Mathias Gehrmann, Pirkko-Liisa Kellokumpu-Lehtinen, Ralph M Wirtz, Heikki Joensuu
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast Cancer. Cancers 13 (14) (2021)
Anne-Sophie Heimes, Franziska Härtner, Katrin Almstedt, Slavomir Krajnak, Antje Lebrecht, Marco J Battista, Karolina Edlund, Walburgis Brenner, Annette Hasenburg, Ugur Sahin, Mathias Gehrmann, Jan G Hengstler, Marcus Schmidt
Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes. International journal of molecular sciences 21 (19) (2020)
Elena Laakmann, Isabell Witzel, Tanja Neunhöffer, Rudolf Weide, Marcus Schmidt, Tjoung-Won Park-Simon, Volker Möbus, Christoph Mundhenke, Arkadius Polasik, Kristina Lübbe, Tobias Hesse, Kerstin Riecke, Marc Thill, Peter Andreas Fasching, Carsten Denkert, Tanja Fehm, Valentina Nekljudova, Julia Rey, Sibylle Loibl, Volkmar Mueller
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases. Cancers 12 (10) (2020)
Marcus Schmidt, Veronika Weyer-Elberich, Jan G Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Aslihan Gerhold-Ay, Antje Lebrecht, Marco J Battista, Annette Hasenburg, Ugur Sahin, Konstantine T Kalogeras, Pirkko-Liisa Kellokumpu-Lehtinen, George Fountzilas, Ralph M Wirtz, Heikki Joensuu
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population. Breast cancer research : BCR 20 (1) (2018)

Marcus Schmidt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marcus Schmidt